One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Aboy, Mateo
Crespo, Cristina
Liddell, Kathleen
Davey, Neil
Abstract
On the first anniversary of Vanda, 1) to what extent have legal arguments and claim amendments based on Vanda been effective in overcoming 35 USC 101 Mayo-based rejections?; and 2) How are applicants transforming diagnostic patent claims into method of treatment claims to overcome Mayo-based subject matter eligibility rejections?
Description
Keywords
Diagnostic Test Approval, Humans, Patents as Topic
Journal Title
Nat Biotechnol
Conference Name
Journal ISSN
1087-0156
1546-1696
1546-1696
Volume Title
38
Publisher
Springer Science and Business Media LLC
Publisher DOI
Rights
All rights reserved
Sponsorship
Wellcome Trust (105602/Z/14/Z)
Novo Nordisk Foundation (via University of Copenhagen) (NNF17SA0027784)
Novo Nordisk Foundation (via University of Copenhagen) (NNF17SA0027784)
Novo Nordisk Foundation Grant number NNF17SA0027784
Cambridge Wellcome Trust ISSF Grant Second phase